Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

ChemWerth to expand in China and India

ChemWerth, a Woodbridge-based supplier and developer of generic drug ingredients, plans to celebrate its 40th year in business by expanding manufacturing partnerships in China and...

| By Kelley Gipson

InveniAI introduces new tool for drug discovery

InveniAI® has introduced ChatAlphaMeld™, a tool designed to provide expert answers and insights for drug and target discovery. The ChatAlphaMeld interface harnesses GPT-4 and AlphaMeld’s extensive...

| By Kelley Gipson

Yale explores role of cellular plasticity in cancer

A recently published Yale study explores how cell plasticity — which refers to the ability of cells to adapt their phenotypes in response to environmental signals without undergoing...

| By Kelley Gipson

FDA clears Butterfly’s AI-enabled lung tool

Butterfly Network reports that it has received 510(k) clearance for an AI-enabled Auto B-line Counter that may simplify how healthcare professionals evaluate adults with suspected diminished...

| By Kelley Gipson

The Roundup – April 6, 2023

View this email in your browser April 6, 2023 Many members of the BioCT Government Affairs Committee spoke at the Legislative Bioscience Caucus‘s April 4th meeting. A full...

| By Kelley Gipson

Yale faculty members named life science leaders

Two Yale University faculty members are among 46 life science leaders in the United States – in academic, government, business, medicine and nonprofits – to...

| By Kelley Gipson

Career Newsletter – April 4, 2023

View this email in your browser April 4, 2023 Alexion  Senior Manager, Patient Services Reporting and Analytics New Haven Associate Scientist III, Small-Molecule Research, Biology...

| By Kelley Gipson

Rallybio drug performs well in clinical trial

New Haven’s Rallybio reports that its drug candidate RLYB212 showed strong results in a proof-of-concept study as a treatment for a rare immune disorder in fetuses and...

| By Kelley Gipson

Protein shape may be key to disarming bacteria

Shigella bacteria can infect humans but not mice. A team from UConn Health has explained why. Their findings may shed light on the multifariousness of a...